Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127099921 | 12709992 | 1 | I | 20160731 | 20160804 | 20160902 | 20160902 | EXP | DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-51456DE | BOEHRINGER INGELHEIM | 78.00 | YR | M | Y | 84.00000 | KG | 20160902 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127099921 | 12709992 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 220 MG | 22512 | 110 | MG | CAPSULE, HARD | BID | ||||||
| 127099921 | 12709992 | 2 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 100 MG | 0 | 100 | MG | QD | |||||||
| 127099921 | 12709992 | 3 | SS | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 127099921 | 12709992 | 4 | SS | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 127099921 | 12709992 | 5 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 7 MG | 0 | 7 | MG | QD | |||||||
| 127099921 | 12709992 | 6 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 127099921 | 12709992 | 7 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127099921 | 12709992 | 1 | Atrial fibrillation |
| 127099921 | 12709992 | 2 | Percutaneous coronary intervention |
| 127099921 | 12709992 | 3 | Coronary arterial stent insertion |
| 127099921 | 12709992 | 4 | Coronary artery disease |
| 127099921 | 12709992 | 5 | Percutaneous coronary intervention |
| 127099921 | 12709992 | 6 | Coronary arterial stent insertion |
| 127099921 | 12709992 | 7 | Coronary artery disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127099921 | 12709992 | HO |
| 127099921 | 12709992 | LT |
| 127099921 | 12709992 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127099921 | 12709992 | Dizziness | |
| 127099921 | 12709992 | Fall | |
| 127099921 | 12709992 | Haemorrhage intracranial | |
| 127099921 | 12709992 | Headache | |
| 127099921 | 12709992 | Laceration | |
| 127099921 | 12709992 | Subdural haemorrhage | |
| 127099921 | 12709992 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127099921 | 12709992 | 1 | 20160430 | 20160731 | 0 |